Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Martin Samuel Bates
SVP AND CFO at Celldex Therapeutics. Filing since 9 Jun 2020.
CIK 0001709024
Company
Date
Role
Action
Shares
Amount
Of holding
CLDX
Celldex Therapeutics, Inc.
14 Jun 2024
SVP AND CFO
Sold at will
17,172
$608.31K
37.9%
CLDX
Celldex Therapeutics, Inc.
30 May 2024
SVP AND CFO
Sold at will
35,000
$1.19M
58.2%
CLDX
Celldex Therapeutics, Inc.
12 Aug 2022
SVP AND CFO
Sold, plan not stated
17,547
$639.63K
41.9%
CLDX
Celldex Therapeutics, Inc.
11 Aug 2022
SVP AND CFO
Sold, plan not stated
2,453
$90.86K
9.1%
CLDX
Celldex Therapeutics, Inc.
23 Dec 2021
SVP and CFO
Sold, plan not stated
9,500
$399.00K
28.0%
CLDX
Celldex Therapeutics, Inc.
15 Nov 2021
SVP and CFO
Sold, plan not stated
9,500
$413.88K
26.1%
CLDX
Celldex Therapeutics, Inc.
10 Aug 2021
SVP and CFO
Sold, plan not stated
2,738
$123.89K
12.6%
CLDX
Celldex Therapeutics, Inc.
9 Jun 2020
SVP and CFO
Bought
9,750
$29.74K
990%
8 decisions on file.
